Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, offering promising improvements throughout various healthcare and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA delivers a safer, a lot more trusted alternate for therapeutic use, specially